Characteristics | N | % |
---|---|---|
Age at initial disease, mean (range) | 59 (20–76) | |
≤ 60 | 13 | 50.0 |
> 60 | 13 | 50.0 |
Gender | ||
Male | 14 | 53.8 |
Female | 12 | 46.2 |
Primary site | ||
Lymph node | 12 | 46.2 |
Extranodal | 14 | 53.8 |
Breast | 4 | 15.4 |
Testicular | 3 | 11.5 |
Others | 7 | 26.9 |
CNS Relapse Type | ||
Isolated disease | 21 | 80.8 |
CNS with disease progression | 1 | 3.8 |
Combined disease | 5 | 15.4 |
CNS relapse time, median (range) | 3 (0–10) | |
< 5 years | 19 | 73.1 |
≥ 5 years | 7 | 26.9 |
Performance Status at CNS relapse | ||
0–1 | 18 | 69.2 |
2–4 | 8 | 30.8 |
Diagnosis approaches | ||
Biopsy or surgery resection | 24 | 92.3 |
Enhanced MRI | 2 | 7.7 |